Major James seems to be pretty upbeat in his letter to the ASX ref Freeborn 1.Selling at present SP seems pointless and not smart, especially with so much good news in the pipeline. Rgds.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%